Exercise-induced asthma in children

被引:9
作者
Massie J. [1 ]
机构
[1] Department of Respiratory Medicine, Murdoch Children's Res. Institute, Royal Children's Hospital, Parkville
关键词
Budesonide; Fluticasone Propionate; Salmeterol; Montelukast; Formoterol;
D O I
10.2165/00128072-200204040-00006
中图分类号
学科分类号
摘要
Exercise-induced asthma (EIA) is a relatively common problem in children, but may not be recognized because children either do not report their symptoms, or avoid activities that cause it. Clarifying the diagnosis of EIA, in particular separating EIA from other causes of exertional dyspnea, is essential. Treating EIA in children is challenging because of the nature of their physical activities, which are often not planned, and may be prolonged. Keeping children active is an important goal to ensure healthy physical and social development. Many children with EIA are well managed with an inhaled short-acting β2-adrenoceptor agonist before exercise or if symptoms develop. The approach to more troublesome EIA depends on whether the child has persistent asthma and requires better prevention, or the EIA is an isolated clinical problem. The options for treatment also depend on the timing, frequency, and duration of activity that induces EIA. Options include the addition of a cromone, a leukotriene modifier, an inhaled corticosteroid, or switching to use a long-acting β2-adrenoceptor agonist. The use of warm-up exercises has been shown to be helpful by using the refractory period but is not practical for most children with EIA. A final consideration for successful management of EIA in children is that the delivery of medication needs to be age-appropriate.
引用
收藏
页码:267 / 278
页数:11
相关论文
共 107 条
  • [1] Joseph C.L., Foxman B., Leickly F.E., Et al., Prevalence of possible undiagnosed asthma and associated morbidity among urban school children, J Pediatr, 129, 5, pp. 735-742, (1996)
  • [2] Haby M.M., Peat J.K., Mellis C.M., Et al., An exercise challenge for epidemiological studies of childhood asthma: Validity and repeatability, Eur Respir J, 8, 5, pp. 729-736, (1995)
  • [3] Backer V., Ulrik C.S., Bronchial responsiveness to exercise in a random sample of 494 children and adolescents from Copenhagen, Clin Exp Allergy, 22, 8, pp. 741-747, (1992)
  • [4] Weiss S.T., Tager I.B., Weiss J.W., Et al., Airways responsiveness in a population sample of adults and children, Am Rev Respir Dis, 129, 6, pp. 898-902, (1984)
  • [5] Milgrom H., Taussig L.M., Keeping children with exercise-induced asthma active, Pediatrics, 104, 3, (1999)
  • [6] Randolph C., Exercise-induced asthma: Update on pathophysiology, clinical diagnosis, and treatment, Curr Probl Pediatr, 27, 2, pp. 53-77, (1997)
  • [7] Boner A.L., Spezia E., Piovesan P., Et al., Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children, Am J Respir Crit Care Med, 149, 4 PART 1, pp. 935-939, (1994)
  • [8] Mussaffi H., Springer C., Godfrey S., Increased bronchial responsiveness to exercise and histamine after allergen challenge in children with asthma, J Allergy Clin Immunol, 77, 1 PART 1, pp. 48-52, (1986)
  • [9] Hofstra W.B., Neijens H.J., Duiverman E.J., Et al., Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma, Pediatric Pulmonol, 29, 6, pp. 415-423, (2000)
  • [10] Bierman C.W., Spiro S.G., Petheram I., Characterization of the late response in exercise-induced asthma, J Allergy Clin Immunol, 74, 5, pp. 701-706, (1984)